Literature DB >> 12695460

Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass.

M Chello1, P Mastroroberto, G Patti, A D'Ambrosio, M Cortez Morichetti, G Di Sciascio, E Covino.   

Abstract

OBJECTIVE: To investigate the effects of preoperative simvastatin treatment on leucocyte-endothelial interactions following coronary artery bypass surgery with cardiopulmonary bypass.
DESIGN: Double blind crossover study. Experiments on polymorphonuclear cells (neutrophils) were done at the end of cardiopulmonary bypass and one hour postoperatively. Endothelial P-selectin expression and neutrophil/endothelial adhesion were evaluated under either normoxic or hypoxic conditions.
SETTING: University hospital (tertiary referral centre). PATIENTS: Three groups of patients undergoing coronary bypass surgery: 20 patients taking simvastatin for cholesterol control, 16 patients not responsive to simvastatin, and 20 controls. MAIN OUTCOME MEASURES: Expression of neutrophil CD11b and endothelial P-selectin; adhesion of neutrophils to endothelium.
RESULTS: Cardiopulmonary bypass resulted in a significant increase in neutrophil CD11b expression in all groups. Similarly, the exposure of saphenous vein to hypoxia/reoxygenation induced an augmentation of endothelial P-selectin. However, both neutrophil CD11b expression and endothelial P-selectin exocytosis were less in the simvastatin groups than in the controls. Cardiopulmonary bypass and controlled hypoxia/reoxygenation stimulated neutrophil/endothelial adhesion, but the number of adhering cells was less in the simvastatin groups than in the controls, irrespective of the cholesterol concentration. Treatment of endothelial cells with L-NAME completely reversed the effects of simvastatin.
CONCLUSIONS: Pretreatment with simvastatin reduces neutrophil adhesion to the venous endothelium in patients undergoing coronary surgery, irrespective of its efficacy at lowering cholesterol concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695460      PMCID: PMC1767656          DOI: 10.1136/heart.89.5.538

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  39 in total

1.  Emerging mechanisms for secondary cardioprotective effects of statins.

Authors:  S J Miller
Journal:  Cardiovasc Res       Date:  2001-10       Impact factor: 10.787

2.  Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study.

Authors:  E Florens; S Salvi; J Peynet; C Elbim; Z Mallat; A Bel; A Nguyen; A Tedgui; C Pasquier; P Menasché
Journal:  J Card Surg       Date:  2001 May-Jun       Impact factor: 1.620

3.  Nitric oxide: an endogenous modulator of leukocyte adhesion.

Authors:  P Kubes; M Suzuki; D N Granger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.

Authors:  D Pinsky; M Oz; H Liao; S Morris; J Brett; R Sciacca; M Karakurum; M Van Lookeren Campagne; J Platt; R Nowygrod
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 5.  Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia.

Authors:  A M Lefer; P S Tsao; D J Lefer; X L Ma
Journal:  FASEB J       Date:  1991-04       Impact factor: 5.191

6.  The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery.

Authors:  P Menasché
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

Review 7.  Systemic inflammation and cardiac surgery: an update.

Authors:  G Asimakopoulos
Journal:  Perfusion       Date:  2001-09       Impact factor: 1.972

8.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.

Authors:  I Kurose; D C Anderson; M Miyasaka; T Tamatani; J C Paulson; R F Todd; J R Rusche; D N Granger
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

9.  Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.

Authors:  X L Ma; A S Weyrich; D J Lefer; A M Lefer
Journal:  Circ Res       Date:  1993-02       Impact factor: 17.367

10.  Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils.

Authors:  K D Patel; G A Zimmerman; S M Prescott; R P McEver; T M McIntyre
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

View more
  11 in total

Review 1.  WITHDRAWN: Preoperative statin therapy for patients undergoing cardiac surgery.

Authors:  Elmar W Kuhn; Ingo Slottosch; Thorsten Wahlers; Oliver J Liakopoulos
Journal:  Cochrane Database Syst Rev       Date:  2016-05-24

Review 2.  Statin therapy in renal disease: harmful or protective?

Authors:  Peter A McCullough; Leslie R Rocher
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

3.  Evidence for simvastatin anti-inflammatory actions based on quantitative analyses of NETosis and other inflammation/oxidation markers.

Authors:  Walid M Al-Ghoul; Margarita S Kim; Nadeem Fazal; Anser C Azim; Ashraf Ali
Journal:  Results Immunol       Date:  2014-03-25

4.  Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3.

Authors:  Maria Risager Jensen; Goran Bajic; Xianwei Zhang; Anne Kjær Laustsen; Heidi Koldsø; Katrine Kirkeby Skeby; Birgit Schiøtt; Gregers R Andersen; Thomas Vorup-Jensen
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

5.  Effects of simvastatin on cardiohemodynamic responses to ischemia-reperfusion in isolated rat hearts.

Authors:  Xia Zheng; Shen-Jiang Hu
Journal:  Heart Vessels       Date:  2006-03       Impact factor: 2.037

6.  Statin therapy in renal disease: harmful or protective?

Authors:  Peter A McCullough; Leslie R Rocher
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

7.  Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin.

Authors:  Elizabeth Sapey; Jaimin M Patel; Hannah L Greenwood; Georgia M Walton; Jon Hazeldine; Charendeep Sadhra; Dhruv Parekh; Rachel C A Dancer; Peter Nightingale; Janet M Lord; David R Thickett
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

8.  The Effect of Statins and Other Cardiovascular Medication on Ischemia-Reperfusion Damage in a Human DIEP Flap Model: Theoretical and Epidemiological Considerations.

Authors:  M G W van den Heuvel; A Bast; A W Ambergen; R R W J van der Hulst
Journal:  J Transplant       Date:  2012-05-09

9.  Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy.

Authors:  Basem Azab; Masood A Shariff; Rana Bachir; John P Nabagiez; Joseph T McGinn
Journal:  J Cardiothorac Surg       Date:  2013-09-27       Impact factor: 1.637

Review 10.  Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review.

Authors:  Catherine Morgan; Michael Zappitelli; Peter Gill
Journal:  Crit Care       Date:  2009-10-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.